Kinoxis team.We recently announced Kinoxis Therapeutics Pty Ltd $14.5M Series B and our participation in this round. The funds raised will advance their lead candidate (KNX100) into Phase 2 clinical trials targeting agitation and aggression…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2024/09/11lSOK0WxCkC78BI-uCfsaw.jpeg415739Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2024-09-01 13:20:232024-09-06 11:05:09Why we doubled down on Kinoxis.
Meet the newest addition to the Stoic investment teamWith a diverse background spanning start-ups and venture building across Europe, Safaa is eager to leverage her expertise to drive advancements and innovation in healthcare. Her journey, fuelled…
2023 has been another big year at Stoic. We first provide commentary on the venture market this year. We then dig into what we’ve been up to in the past 12 months.Observations of the venture marketThere were a few narratives that dominated…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2023/12/1TwkY1jNQST4dx99e5PiP1Q.png788940Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-12-22 00:16:212024-01-10 15:05:08Stoic’s Year in review 2023
2023 has been another big year at Stoic. We first provide commentary on the venture market this year. We then dig into what we’ve been up to in the past 12 months.Observations of the venture marketThere were a few narratives that dominated…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2023/12/1TwkY1jNQST4dx99e5PiP1Q.png788940Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-12-22 00:16:212023-12-24 16:30:14Year in review 2023
2023 has been another big year at Stoic. We first provide a commentary on the state of the markets. We then dig into what we’ve been up to in the past 12 months.Observations of the venture marketThere were a few narratives that dominated…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2023/12/1TwkY1jNQST4dx99e5PiP1Q.png788940Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-12-22 00:16:212023-12-24 11:35:08Year in review 2023 : Observations of the venture market
A primer on building Neurotech — part 2In part 1 we examined product development and defensibility.In part 2, we look at product delivery and best practice strategies for regulation and reimbursement.Successful product delivery = Longitudinal…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2023/12/1iDRfFxyLc9KjElgMCaNa6g.png7681024Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-12-12 10:55:482023-12-12 23:05:09A primer on building Neurotech — part 2
A primer on building Neurotech — part 1The thesis for Neurotech is that by interfacing directly with the nervous system, we can more accurately map the pathophysiology of various neurological & psychiatric disorders. Not just at discrete…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2023/11/1h68uSQBC9pbu4Kzz_EKyyg.png5121024Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-11-21 00:37:202023-11-21 21:05:11A primer on building Neurotech — part 1
We’re pleased to be leading Lenexa’s pre-series A, a team bridging geriatric care with the future of preventive medicine.Co-founders Will Yang + Ajit RavindranThe burden of immobility.Our rapidly ageing population and stagnating labor growth…
Harikesh Pushpapathan
https://stoicvc.com.au/wp-content/uploads/2023/11/1e2u4m1HQ5LWzEuvDIWg5uA.jpeg788940Harikesh Pushpapathanhttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngHarikesh Pushpapathan2023-02-13 00:39:092023-11-21 22:00:20Our Investment in Lenexa
Core team: Geoff Waring, Guy Hedley, Harikesh PushpapathanDespite the visible slowdown in venture this year, we’ve kept our foot on the gas. We know that advancements in emerging science and deep technologies occur through all market cycles.…
Stoic VC
https://stoicvc.com.au/wp-content/uploads/2023/11/1GrFfX-xiOaWH0m2p1TkiYQ.jpeg788940Stoic VChttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngStoic VC2022-12-14 05:50:322023-12-18 15:35:082022: Year in Review
Core team: Geoff Waring, Guy Hedley, Harikesh PushpapathanDespite the visible slowdown in venture this year, we’ve kept our foot on the gas. We know that advancements in emerging science and deep technologies occur through all market cycles.…
Stoic VC
https://stoicvc.com.au/wp-content/uploads/2022/12/1NmAn7kgQUvhfGD0T3deFGw.png6821024Stoic VChttps://stoicvc.com.au/wp-content/uploads/2023/04/Screen-Shot-2023-04-25-at-5.44.30-pm-300x137.pngStoic VC2022-12-14 05:50:322023-05-18 21:30:202022 Year in Review
